Drug Profile


Alternative Names: ADD 03055; CW 554; Felbamyl; Felbatol; Taloxa; W 554

Latest Information Update: 20 Sep 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Meda Pharmaceuticals
  • Developer AESCA; Essex Chemie; Meda Pharmaceuticals; Merck & Co
  • Class Antiepileptic drugs; Phenylcarbamates; Propylene glycols; Small molecules
  • Mechanism of Action NMDA receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Epilepsy; Lennox-Gastaut syndrome

Most Recent Events

  • 19 Sep 2011 First generic equivalent available in USA
  • 07 Dec 1999 Registered for Epilepsy in Austria (PO)
  • 07 Dec 1999 Registered for Epilepsy in Belgium (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top